BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23071240)

  • 1. Methods in comparative effectiveness research.
    Armstrong K
    J Clin Oncol; 2012 Dec; 30(34):4208-14. PubMed ID: 23071240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some methodological points to consider when performing systematic reviews in comparative effectiveness research.
    Berlin JA; Cepeda MS
    Clin Trials; 2012 Feb; 9(1):27-34. PubMed ID: 22049086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.
    Goddard KA; Knaus WA; Whitlock E; Lyman GH; Feigelson HS; Schully SD; Ramsey S; Tunis S; Freedman AN; Khoury MJ; Veenstra DL
    Genet Med; 2012 Jul; 14(7):633-42. PubMed ID: 22516979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining comparative effectiveness research: the importance of getting it right.
    Sox HC
    Med Care; 2010 Jun; 48(6 Suppl):S7-8. PubMed ID: 20473202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.
    Chalkidou K; Tunis S; Whicher D; Fowler R; Zwarenstein M
    Clin Trials; 2012 Aug; 9(4):436-46. PubMed ID: 22752634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-Care Clinical Trials in Sports Medicine Research: Identifying Effective Treatment Interventions Through Comparative Effectiveness Research.
    Lam KC; Bacon CEW; Sauers EL; Bay RC
    J Athl Train; 2020 Mar; 55(3):217-228. PubMed ID: 31618071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of methods for comparative effectiveness research.
    Meyer AM; Wheeler SB; Weinberger M; Chen RC; Carpenter WR
    Semin Radiat Oncol; 2014 Jan; 24(1):5-13. PubMed ID: 24314337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of observational investigations in comparative effectiveness research.
    Marko NF; Weil RJ
    Value Health; 2010 Dec; 13(8):989-97. PubMed ID: 21138497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methods of comparative effectiveness research.
    Sox HC; Goodman SN
    Annu Rev Public Health; 2012 Apr; 33():425-45. PubMed ID: 22224891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.
    Oderda GM; Balfe LM
    J Manag Care Pharm; 2011; 17(9 Suppl B):S19-24. PubMed ID: 22073936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for CER.
    Lowry SJ; Loggers ET; Bowles EJ; Wagner EH
    Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP77-83. PubMed ID: 22693985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to answering critical CER questions.
    Kinnier CV; Chung JW; Bilimoria KY
    Cancer Treat Res; 2015; 164():1-14. PubMed ID: 25677015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness research: opportunities in surgical oncology.
    Neuman HB; Greenberg CC
    Semin Radiat Oncol; 2014 Jan; 24(1):43-8. PubMed ID: 24314341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness research paradigm: implications for systematic reviews and clinical practice guidelines.
    Brouwers MC; Thabane L; Moher D; Straus SE
    J Clin Oncol; 2012 Dec; 30(34):4202-7. PubMed ID: 23071227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can CER be an effective tool for change in the development and assessment of new drugs and technologies?
    Brixner DI; Watkins JB
    J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S06-11. PubMed ID: 22663293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.
    Ryan R; Santesso N; Lowe D; Hill S; Grimshaw J; Prictor M; Kaufman C; Cowie G; Taylor M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007768. PubMed ID: 24777444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Which research is needed to support clinical decision-making on integrative medicine? Can comparative effectiveness research close the gap?].
    Witt CM; Huang WJ; Lao L; Berman BM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Aug; 33(8):1030-5. PubMed ID: 24325048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.